Who owns LIPOCINE INC NEW?
- Ticker: LPCN
- CUSIP Number: 53630x203
Tip: Access positions for across all investors
Analyze quarterly positions in Lipocine with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Lipocine stock
Who bought or sold LIPOCINE INC NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Group | 222k | $618k | 0% | Dec 2023 |
|
| Two Sigma Advisers | 26k | $73k | -54% | Dec 2023 |
|
| Caldwell Sutter Capital | 471.00 | $2.4k | 0% | Mar 2024 |
|
| Royal Bank of Canada | 91.00 | $0 | 18% | Dec 2023 |
|
| Advisor Group Holdings | 68.00 | $188.999200 | 0% | Dec 2023 |
|
| Tidemark | 59.00 | $164.999400 | 100% | Dec 2023 |
|
| Wells Fargo & Company | 41.00 | $114.000500 | 5% | Dec 2023 |
|
| Jpmorgan Chase & Co | 9.00 | $25.000200 | -95% | Dec 2023 |
|
| Bank of America Corporation | 6.00 | $16.000200 | -90% | Dec 2023 |
|
Who sold out of Lipocine?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Kestra Advisory Services | Sep 2023 | 17k | $50k |
| Wealth Effects | Dec 2023 | 15k | $41k |
| UBS Group | Sep 2023 | 42.00 | $125.000400 |